| PRD_000992 | Name: | HMB-Val-Ser-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | Formula: | C28 H40 N4 O7 S | Definition date: | 2013-01-30 | Last modified: | 2013-01-30 |
|
| PRD_000993 | Name: | N3Phe-Phe(4-NH2CH2)-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | Formula: | C37 H50 N8 O5 S | Definition date: | 2013-01-30 | Last modified: | 2013-01-30 |
|
| PRD_001016 | Name: | Glidobactin | Formula: | C27 H46 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
| PRD_001018 | Name: | Cepafungin I | Formula: | C28 H48 N4 O6 | Definition date: | 2013-02-06 | Last modified: | 2023-11-03 |
|
| PRD_000776 | Name: | Lyngbyastatin 7 | Formula: | C48 H66 N8 O12 | Definition date: | 2013-02-06 | Last modified: | 2013-06-03 |
|
| PRD_000830 | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | Formula: | C35 H35 Br Cl N4 O10 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
| PRD_000865 | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | Formula: | C31 H31 Br Cl N4 O6 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
| PRD_000866 | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | Formula: | C29 H32 Br N4 O10 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
| PRD_000868 | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | Formula: | C25 H28 Br N4 O6 P | Definition date: | 2013-02-06 | Last modified: | 2013-02-06 |
|
| PRD_001054 | Name: | peptide inhibitor, syc59 | Formula: | C24 H38 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_001061 | Name: | peptide inhibitor, syc 10 | Formula: | C30 H42 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_001062 | Name: | peptide inhibitor, syc8 | Formula: | C28 H38 N4 O6 | Definition date: | 2013-02-20 | Last modified: | 2013-06-03 |
|
| PRD_000941 | Name: | [Aba5,14]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_000998 | Name: | [Aba3,16]BTD-2 | Formula: | C80 H150 N36 O18 S4 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001002 | Name: | [Aba3,7,12,16]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001006 | Name: | [Aba5,7,12,14]BTD-2 | Formula: | C82 H156 N36 O18 S2 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_001009 | Name: | [Aba3,5,7,12,14,16]BTD-2 | Formula: | C84 H162 N36 O18 | Definition date: | 2013-02-27 | Last modified: | 2013-06-03 |
|
| PRD_000967 | Name: | macrocyclic peptidomimetic | Formula: | C56 H84 N16 O9 | Definition date: | 2013-03-06 | Last modified: | 2013-06-07 |
|
| PRD_000882 | Name: | MonodeChloro- Teicoplanin A2-2 | Formula: | C88 H98 Cl N9 O33 | Definition date: | 2013-03-06 | Last modified: | 2013-06-03 |
|
| PRD_000889 | Name: | (2R,4R)-4-methyl-1-(N~2~-{[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-arginyl)piperidine-2-carboxylic
acid | Formula: | C23 H36 N6 O5 S | Definition date: | 2013-03-13 | Last modified: | 2013-03-13 |
|
| PRD_000960 | Name: | N-[(benzyloxy)carbonyl]-L-valyl-L-alpha-glutamyl-N-[(2R)-1-carboxy-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butan-2-yl]-L-isoleucinamide | Formula: | C35 H42 F4 N4 O11 | Definition date: | 2013-03-20 | Last modified: | 2013-06-03 |
|
| PRD_000922 | Name: | PL-42 | Formula: | C39 H63 N9 O14 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
| PRD_000780 | Name: | PL-49 | Formula: | C36 H63 N9 O11 P S | Definition date: | 2013-04-03 | Last modified: | 2013-06-03 |
|
| PRD_000903 | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-{3-oxo-3-[(pyridin-3-ylmethyl)amino]propyl}butanamide | Formula: | C15 H23 N3 O4 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|
| PRD_000907 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide | Formula: | C26 H41 N3 O5 | Definition date: | 2013-04-10 | Last modified: | 2013-04-10 |
|